|
Q3 FY2017
As of Mar 31, 2017
|
Q2 FY2017
As of Dec 31, 2016
|
Q1 FY2017
As of Sep 30, 2016
|
Q4 FY2016
As of Jun 30, 2016
|
Q3 FY2016
As of Mar 31, 2016
|
Q2 FY2016
As of Dec 31, 2015
|
Q1 FY2016
As of Sep 30, 2015
|
Q2 FY2014
As of Jan 31, 2014
|
Q3 FY2013
As of Apr 30, 2013
|
Q2 FY2013
As of Jan 31, 2013
|
Q1 FY2013
As of Oct 31, 2012
|
Q4 FY2012
As of Jul 31, 2012
|
Q3 FY2012
As of Apr 30, 2012
|
Q2 FY2012
As of Jan 31, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||
| Cash | ||||||||||||||
| Amounts receivable | ||||||||||||||
| Inventory | ||||||||||||||
| Total Current Assets | ||||||||||||||
| Deposits | ||||||||||||||
| Property and equipment, net | ||||||||||||||
| Total non-current assets | ||||||||||||||
| TOTAL ASSETS | ||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIENCY | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Bank indebtedness | ||||||||||||||
| Accounts payable | ||||||||||||||
| Accrued liabilities | ||||||||||||||
| Convertible notes payable | ||||||||||||||
| Current portion of deferred lease incentive | ||||||||||||||
| Due to related parties (Note 4) | ||||||||||||||
| Due to related parties | ||||||||||||||
| Total Current Liabilities | ||||||||||||||
| Deferred lease incentive | ||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||
| STOCKHOLDERS' DEFICIENCY | ||||||||||||||
| Common Stock 300,000,000 shares authorized, at $0.001 par value: 66,937,845 shares issued and outstanding | ||||||||||||||
| Additional Paid-In Capital | ||||||||||||||
| Accumulated Other Comprehensive Income | ||||||||||||||
| Accumulated Deficit | ||||||||||||||
| Total Stockholders' Deficiency | ||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY | ||||||||||||||
Loading...